Targeting Critical Pain Points in Traumatic Wound Care
Market Opportunity Overview
Our near-term commercial focus is driven by a compelling market opportunity rooted in addressing critical pain points in wound care. We aim to simplify and enhance the current standard of care by offering a single, straightforward solution that not only controls bleeding and prevents infection but also improves wound healing.
Initial Market Focus
Our initial market focus centers on addressing traumatic wounds, both in civilian and military settings. This choice is driven by the profound impact we can make in these critical scenarios. The significance of our commercial impact is underscored by two key factors: the severity of the conditions we treat and the frequency of their occurrence.
Hemorrhage, or excessive blood loss due to traumatic injury, is the leading cause of mortality for Americans aged one to 46. In combat settings, it is the primary contributor to preventable deaths.
Wound infections affect patients 5-7% of the time, depending on wound mechanisms, contamination, and access to definitive care. These infections introduce substantial complications, increasing morbidity, mortality, healthcare costs, and recovery timelines.
Market Size
The acute wound care market, valued at $8.25 billion USD in 2021, is driven by an increase in traumatic accidents, injuries, and workplace incidents. This includes post-trauma care, surgical procedures, and incisions, all within the addressable market for our offering.
While this market estimate is substantial, it may be conservative given our potential to reduce preventable deaths from hemorrhage. Our product has the capacity to disrupt the broader wound care market, with the potential for widespread adoption across trauma, emergency medicine, surgery, and other clinical areas.
